DarioHealth (DRIO) Common Equity (2012 - 2026)

DarioHealth (DRIO) has reported Common Equity for 15 consecutive years, with $55.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 13.91% year-over-year to $55.1 million; the trailing twelve-month figure through Jun 2026 stood at $55.1 million (down 13.91% YoY), and the FY2025 full-year result was $67.9 million, down 5.69% from the prior year.
• Common Equity declined to $55.1 million in Q2 2026 per DRIO's latest filing, from $62.4 million in the prior quarter.
• Across five years, Common Equity topped out at $114.2 million in Q1 2022 and bottomed at $55.1 million in Q2 2026.
• Historically, Common Equity has averaged $74.1 million across 5 years, with a median of $72.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Common Equity sank 36.92% in 2023, then climbed 28.07% in 2025.
• Over 5 years, Common Equity stood at $80.0 million in 2022, then slipped by 27.32% to $58.1 million in 2023, then climbed by 23.86% to $72.0 million in 2024, then retreated by 5.69% to $67.9 million in 2025, then dropped by 18.9% to $55.1 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $55.1 million, $62.4 million, and $67.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.